The effect of smoking on the risk of gestational diabetes mellitus and the OGTT profile during pregnancy

Diabetes Res Clin Pract. 2019 Dec:158:107901. doi: 10.1016/j.diabres.2019.107901. Epub 2019 Nov 11.

Abstract

Objective: To analyze the relationship between smoking and the risk of GDM, as well as with the OGTT profile during pregnancy.

Patients and methods: A total of 7437 pregnant women were studied. OGTT was performed at the 3rd trimester. Women were categorized as non-smokers (A), as those who ceased smoking at pregnancy (B), and as smokers (C).

Results: 5434 (73.1%) women were group A, 1191 (16%) group B and 812 (10.9%) group C. The rates of GDM among the groups were: A 33.7%, B 34.2%, C 34.2% (ns). However, the number of individuals requiring insulin treatment was significantly different: A 39.2%, B 47.5%, C 50.6% (p < 0.001). Regarding OGTT, fasting glucose levels were significantly higher in group C (89 ± 13 vs 86 ± 12 mg/dl) compared to A, whereas 3-h glucose values were significantly lower (104 ± 33 vs 112 ± 32 mg/dl) (p < 0.001). Group B demonstrated intermediate glucose concentrations. Similar findings were observed in women without GDM. In women with GDM, higher 1-h glucose levels were measured in group C (210 ± 31 vs 205 ± 28 mg/dl) compared with A (p = 0.024). Further, group C sub-analysis found that those who smoked more than 10 cigarettes showed significantly lower 3-h glucose levels (111 ± 31 vs 128 ± 40 mg/dl) compared to those who smoked less than 10 (p = 0.006). HbA1c in women with GDM was higher in group C (4.6 ± 0.6 vs 4.5 ± 0.6%) compared with A (p = 0.027).

Conclusions: The present study did not show any correlation between smoking and GDM risk. However, OGTT profile and HbA1c differed according to smoking status in women with and without GDM.

Keywords: Diabetes; Gestational; OGTT; Pregnancy; Smoking.

MeSH terms

  • Adult
  • Blood Glucose / analysis*
  • Diabetes, Gestational / physiopathology*
  • Female
  • Glucose Tolerance Test / methods*
  • Humans
  • Pregnancy
  • Smoking / adverse effects*

Substances

  • Blood Glucose